Boston Scientific Total Non-Operating Income/Expense 2010-2024 | BSX

Boston Scientific annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
  • Boston Scientific total non-operating income/expense for the quarter ending September 30, 2024 was $-0.065B, a 22.62% decline year-over-year.
  • Boston Scientific total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.310B, a 8.39% increase year-over-year.
  • Boston Scientific annual total non-operating income/expense for 2023 was $-0.358B, a 29.53% decline from 2022.
  • Boston Scientific annual total non-operating income/expense for 2022 was $-0.508B, a 313.01% increase from 2021.
  • Boston Scientific annual total non-operating income/expense for 2021 was $-0.123B, a 12400% decline from 2020.
Boston Scientific Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $-358
2022 $-508
2021 $-123
2020 $1
2019 $-831
2018 $-85
2017 $-353
2016 $-270
2015 $-367
2014 $-208
2013 $-343
2012 $-239
2011 $-262
2010 $-407
2009 $-414
Boston Scientific Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-09-30 $-65
2024-06-30 $-100
2024-03-31 $-67
2023-12-31 $-78
2023-09-30 $-84
2023-06-30 $-88
2023-03-31 $-108
2022-12-31 $-6
2022-09-30 $-114
2022-06-30 $-78
2022-03-31 $-310
2021-12-31 $-61
2021-09-30 $95
2021-06-30 $-112
2021-03-31 $-45
2020-12-31 $256
2020-09-30 $-22
2020-06-30 $-109
2020-03-31 $-124
2019-12-31 $-216
2019-09-30 $-292
2019-06-30 $-239
2019-03-31 $-84
2018-12-31 $-24
2018-09-30 $68
2018-06-30 $-45
2018-03-31 $-84
2017-12-31 $-92
2017-09-30 $-68
2017-06-30 $-134
2017-03-31 $-59
2016-12-31 $-51
2016-09-30 $-91
2016-06-30 $-63
2016-03-31 $-65
2015-12-31 $-110
2015-09-30 $-68
2015-06-30 $-114
2015-03-31 $-75
2014-12-31 $-61
2014-09-30 $-61
2014-06-30 $-35
2014-03-31 $-51
2013-12-31 $-68
2013-09-30 $-143
2013-06-30 $-68
2013-03-31 $-64
2012-12-31 $-66
2012-09-30 $-69
2012-06-30 $-31
2012-03-31 $-73
2011-12-31 $-71
2011-09-30 $-63
2011-06-30 $-79
2011-03-31 $-49
2010-12-31 $-118
2010-09-30 $-88
2010-06-30 $-112
2010-03-31 $-89
2009-12-31 $-116
2009-09-30 $-95
2009-06-30 $-95
2009-03-31 $-108
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $133.131B $14.240B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $203.157B 25.91
Stryker (SYK) United States $148.171B 33.39
EssilorLuxottica (ESLOY) France $113.461B 0.00
Medtronic (MDT) Ireland $109.010B 16.19
Haleon (HLN) United Kingdom $42.913B 27.88
Lonza Group Ag (LZAGY) Switzerland $42.122B 0.00
GE HealthCare Technologies (GEHC) United States $37.701B 19.56
ResMed (RMD) United States $34.955B 28.72
Terumo (TRUMY) Japan $29.203B 41.24
Koninklijke Philips (PHG) Netherlands $24.410B 18.68
Zimmer Biomet Holdings (ZBH) United States $22.087B 14.06
Insulet (PODD) United States $18.377B 73.18
Baxter (BAX) United States $16.604B 10.80
Smith & Nephew SNATS (SNN) United Kingdom $11.153B 0.00
BellRing Brands (BRBR) United States $9.468B 37.96
Bio-Rad Laboratories (BIO) United States $8.977B 30.51
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $5.523B 12.83
TG Therapeutics (TGTX) United States $4.720B 0.00
Haemonetics (HAE) United States $4.260B 20.79
ICU Medical (ICUI) United States $4.155B 39.56
Prestige Consumer Healthcare (PBH) United States $4.074B 20.26
Perrigo (PRGO) Ireland $3.716B 10.94
Envista Holdings (NVST) United States $3.487B 25.97
Neogen (NEOG) United States $3.270B 37.72
Agios Pharmaceuticals (AGIO) United States $3.103B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.789B 17.89
QuidelOrtho (QDEL) United States $2.595B 16.70
Warby Parker (WRBY) United States $2.344B 0.00
LeMaitre Vascular (LMAT) United States $2.332B 56.69
Green Thumb Industries (GTBIF) United States $1.964B 34.37
AtriCure (ATRC) United States $1.772B 0.00
InMode (INMD) Israel $1.487B 8.94
Curaleaf Holdings (CURLF) Canada $1.348B 0.00
AdaptHealth (AHCO) United States $1.311B 9.37
Maravai LifeSciences Holdings (MRVI) United States $1.168B 0.00
BioLife Solutions (BLFS) United States $1.041B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.96
Owens & Minor (OMI) United States $0.957B 7.48
CeriBell (CBLL) United States $0.916B 0.00
National Vision Holdings (EYE) United States $0.888B 29.68
Capricor Therapeutics (CAPR) United States $0.839B 0.00
Evolus (EOLS) United States $0.785B 0.00
Verano Holdings (VRNOF) United States $0.608B 0.00
Cresco Labs (CRLBF) United States $0.596B 0.00
VAREX IMAGING (VREX) United States $0.596B 26.47
Surmodics (SRDX) United States $0.559B 0.00
Quanterix (QTRX) United States $0.424B 0.00
Canopy Growth (CGC) Canada $0.404B 0.00
Valneva SE (VALN) France $0.370B 0.00
ZimVie (ZIMV) United States $0.363B 30.63
Omeros (OMER) United States $0.349B 0.00
Viemed Healthcare (VMD) United States $0.335B 31.89
Biote (BTMD) United States $0.330B 7.25
Sanara MedTech (SMTI) United States $0.323B 0.00
Cerus (CERS) United States $0.312B 0.00
OraSure Technologies (OSUR) United States $0.288B 19.30
Zynex (ZYXI) United States $0.249B 52.13
TerrAscend (TSNDF) Canada $0.243B 0.00
Aurora Cannabis (ACB) Canada $0.229B 0.00
Utah Medical Products (UTMD) United States $0.219B 15.15
MacroGenics (MGNX) United States $0.218B 0.00
High Tide (HITI) Canada $0.215B 89.00
Sanuwave Health (SNWV) United States $0.195B 2.74
Jin Medical (ZJYL) China $0.188B 0.00
Zevia PBC (ZVIA) United States $0.162B 0.00
Brainsway (BWAY) Israel $0.161B 96.70
Organigram Holdings (OGI) Canada $0.158B 0.00
FitLife Brands (FTLF) United States $0.143B 17.98
TriSalus Life Sciences (TLSI) United States $0.126B 0.00
Quipt Home Medical (QIPT) United States $0.106B 0.00
Fonar (FONR) United States $0.093B 10.54
Oramed Pharmaceuticals (ORMP) United States $0.093B 23.00
Veru (VERU) United States $0.092B 0.00
Ayr Wellness (AYRWF) United States $0.082B 0.00
Rockwell Medical (RMTI) United States $0.080B 41.50
Modular Medical (MODD) United States $0.073B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
Cellectar Biosciences (CLRB) United States $0.066B 0.00
InterCure (INCR) Israel $0.063B 0.00
Exagen (XGN) United States $0.062B 0.00
MariMed (MRMD) United States $0.059B 0.00
Safety Shot (SHOT) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.052B 0.00
Apyx Medical (APYX) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.026B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.17
SNDL (SNDL) Canada $0.000B 0.00